Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Corcept Therapeutics (CORT) Return on Capital Employed (2016 - 2025)

Corcept Therapeutics' Return on Capital Employed history spans 9 years, with the latest figure at 0.07% for Q4 2025.

  • For Q4 2025, Return on Capital Employed fell 14.0% year-over-year to 0.07%; the TTM value through Dec 2025 reached 0.07%, down 14.0%, while the annual FY2025 figure was 0.07%, 17.0% down from the prior year.
  • Return on Capital Employed for Q4 2025 was 0.07% at Corcept Therapeutics, down from 0.1% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.34% in Q1 2022 and bottomed at 0.07% in Q4 2025.
  • The 5-year median for Return on Capital Employed is 0.21% (2021), against an average of 0.21%.
  • The largest annual shift saw Return on Capital Employed rose 13bps in 2022 before it fell -14bps in 2025.
  • A 5-year view of Return on Capital Employed shows it stood at 0.21% in 2021, then increased by 10bps to 0.23% in 2022, then fell by -8bps to 0.21% in 2023, then fell by -4bps to 0.2% in 2024, then tumbled by -67bps to 0.07% in 2025.
  • Per Business Quant, the three most recent readings for CORT's Return on Capital Employed are 0.07% (Q4 2025), 0.1% (Q3 2025), and 0.2% (Q4 2024).